Delandistrogene Moxeparvovec: Side Effects, Uses & Monitoring
Facts extracted from current FDA product labeling for Delandistrogene Moxeparvovec. Educational only — not medical advice.
Labeled uses
ELEVIDYS is indicated for the treatment of patients 4 years of age and older with Duchenne muscular dystrophy (DMD), who are ambulatory and have a confirmed mutation in the DMD gene [see Clinical Pharmacology (12.2 ), Clinical Studies (14 )] .
Source: FDA labeling via NIH DailyMed (set 3525abcd…). Not affiliated with FDA or NIH.
Medical disclaimer: Always consult a qualified healthcare professional about any medication.